Table 6.
Cardiovascular risk factors and current azathioprine use
| Factor | Azathioprine (N = 10) | No Azathioprine (N = 89) | P | P (Adjusted) |
|---|---|---|---|---|
| Systolic BP (mm Hg) | 117.9 ± 18.3 | 119.8 ± 17.7 | 0.83 | 0.53 |
| Diastolic BP (mm Hg) | 66.7 ± 16.1 | 74.6 ± 13.4 | 0.16 | 0.034 |
| HDL cholesterol (mg/dL) | 53.9 ± 15.0 | 47.3 ± 14.7 | 0.15 | 0.09 |
| LDL cholesterol (mg/dL) | 89.3 ± 26.2 | 107.2 ± 38.0 | 0.09 | 0.09 |
| Triglycerides (mg/dL) | 98.9 ± 39.7 | 121.7 ± 60.9 | 0.37 | 0.22 |
| Glucose (mg/dL) | 84.3 ± 11.4 | 87.5 ± 28.2 | 0.81 | 0.77 |
| Homocysteine(umol/L) | 9.62 ± 3.40 | 9.25 ± 2.72 | 0.90 | 0.90 |
| F2 Isoprostane (ng/mg Creatinine) | 3.38 ± 1.78 | 2.78 ± 2.42 | 0.21 | 0.16 |
P = unadjusted P values; P (adjusted) = adjusted for age, sex, and SLEDAI. Data are shown as mean ± SD.